PMC:7274950 / 2485-2580
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T31 | 0-10 | PR:000008015 | denotes | Agalsidase |
T32 | 51-55 | CHEBI:33290;CHEBI:33290 | denotes | Food |
T33 | 60-64 | CHEBI:23888;CHEBI:23888 | denotes | Drug |
T70752 | 0-10 | PR:000008015 | denotes | Agalsidase |
T86774 | 51-55 | CHEBI:33290;CHEBI:33290 | denotes | Food |
T28077 | 60-64 | CHEBI:23888;CHEBI:23888 | denotes | Drug |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 11-15 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20 | 0-95 | Sentence | denotes | Agalsidase beta is the only ERT approved by the US Food and Drug Administration since 2003 [6]. |